We are experts in innovative formulations that optimise stability and bioavailability. We offer solutions for solid and liquid dosage forms,  accommodating proteins, antibodies, peptides, live biotherapeutic products, plasmid DNA and oligonucleotides. These tailored formulations can be designed for various delivery routes, including parenteral, oral, nasal, and ophthalmic administration. Eurofins CDMO partners with you to deliver preclinical and early-phase clinical trial materials in the most adapted dosage forms, from sterile to non-sterile batches.

Formulation screening is performed during drug product development and administration. Different type of buffers and excipients are tested in order to stabilise the drug substance taking into account the needs for the applied delivery route. Information gathered during pre-formulation screening will speed up this process.

Various drug delivery routes are selected and compared to one another in terms of stability, efficacy and feasibility. Eurofins CDMO has experience with a wide range of different drug delivery routes, drug delivery systems and drug production technologies.